Found: 69
Select item for more details and to access through your institution.
Radial endobronchial ultrasound with a guide sheath for diagnosis of peripheral cavitary lung lesions: a retrospective study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Successful weaning of a patient with severe COVID-19 pneumonia under prolonged midazolam sedation using morphine.
- Published in:
- Oxford Medical Case Reports, 2022, v. 2022, n. 6, p. 1, doi. 10.1093/omcr/omac051
- By:
- Publication type:
- Article
High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 10, p. 1084, doi. 10.1093/jjco/hyae094
- By:
- Publication type:
- Article
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30676-y
- By:
- Publication type:
- Article
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapy.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e531, doi. 10.1111/ajco.12643
- By:
- Publication type:
- Article
Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2015, v. 11, n. 2, p. 121, doi. 10.1111/ajco.12199
- By:
- Publication type:
- Article
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case report.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1137, doi. 10.1007/s10637-022-01264-0
- By:
- Publication type:
- Article
Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 634, doi. 10.1007/s10637-022-01214-w
- By:
- Publication type:
- Article
Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 361, doi. 10.1007/s10637-021-01203-5
- By:
- Publication type:
- Article
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1106, doi. 10.1007/s10637-021-01076-8
- By:
- Publication type:
- Article
Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 853, doi. 10.1007/s10637-020-01060-8
- By:
- Publication type:
- Article
Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 232, doi. 10.1007/s10637-020-00966-7
- By:
- Publication type:
- Article
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1854, doi. 10.1007/s10637-020-00943-0
- By:
- Publication type:
- Article
Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 211, doi. 10.1007/s10637-019-00882-5
- By:
- Publication type:
- Article
Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1266, doi. 10.1007/s10637-019-00843-y
- By:
- Publication type:
- Article
Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1138, doi. 10.1007/s10637-018-0628-3
- By:
- Publication type:
- Article
Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 696, doi. 10.1007/s10637-018-0581-1
- By:
- Publication type:
- Article
Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 608, doi. 10.1007/s10637-017-0527-z
- By:
- Publication type:
- Article
Prospective Study of Urinary and Serum Cross-Linked N-Telopeptide of Type I Collagen (NTx) for Diagnosis of Bone Metastasis in Patients With Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 4, p. 364, doi. 10.1016/j.cllc.2012.11.006
- By:
- Publication type:
- Article
Pulmonary carcinosarcoma characterized by small round cells with neuroendocrine, myogenic, and chondrogenic differentiation: An extremely rare case.
- Published in:
- Pathology International, 2019, v. 69, n. 5, p. 282, doi. 10.1111/pin.12780
- By:
- Publication type:
- Article
Usefulness of High Suction Pressure for Sufficient Tissue Collection During Endobronchial Ultrasound Guided Transbronchial Needle Aspiration.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082787
- By:
- Publication type:
- Article
Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
- By:
- Publication type:
- Article
Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis.
- Published in:
- Lung, 2014, v. 192, n. 1, p. 191, doi. 10.1007/s00408-013-9516-y
- By:
- Publication type:
- Article
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non−Small Cell Lung Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2322915, doi. 10.1001/jamanetworkopen.2023.22915
- By:
- Publication type:
- Article
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230698, doi. 10.1001/jamanetworkopen.2023.0698
- By:
- Publication type:
- Article
Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7430
- By:
- Publication type:
- Article
Comparison of sampling methods for next generation sequencing for patients with lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 14, p. 2744, doi. 10.1002/cam4.4632
- By:
- Publication type:
- Article
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 1, p. 13, doi. 10.1002/cam4.1234
- By:
- Publication type:
- Article
Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54804-9
- By:
- Publication type:
- Article
CMET-38. IMPACT ON THE CLINICAL COURSE OF EGFR MUTATION ON BRAIN METASTASES FROM NON-SMALL-CELL LUNG CANCER FROM VIEWPOINT OF NEURO-ONCOLOGISTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi61, doi. 10.1093/neuonc/noy148.248
- By:
- Publication type:
- Article
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 1, p. 169, doi. 10.1002/ijc.34700
- By:
- Publication type:
- Article
Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 1, p. 281, doi. 10.1007/s00520-012-1522-8
- By:
- Publication type:
- Article
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 503, doi. 10.1007/s00228-023-03452-0
- By:
- Publication type:
- Article
Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1: A case report.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 11, p. 929, doi. 10.1111/1759-7714.15254
- By:
- Publication type:
- Article
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 85, doi. 10.1111/1759-7714.14738
- By:
- Publication type:
- Article
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 21, p. 2970, doi. 10.1111/1759-7714.14643
- By:
- Publication type:
- Article
HER3 expression is enhanced during progression of lung adenocarcinoma without <italic>EGFR</italic> mutation from stage 0 to IA1.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 4, p. 466, doi. 10.1111/1759-7714.12609
- By:
- Publication type:
- Article
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89006-9
- By:
- Publication type:
- Article
Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report.
- Published in:
- BMC Pharmacology & Toxicology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s40360-020-00404-7
- By:
- Publication type:
- Article
Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under Lung Point guidance for small peripheral pulmonary lesions.
- Published in:
- Respirology, 2013, v. 18, n. 5, p. 834, doi. 10.1111/resp.12095
- By:
- Publication type:
- Article
Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 757, doi. 10.1007/s11523-024-01084-7
- By:
- Publication type:
- Article
Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 6, p. 915, doi. 10.1007/s11523-023-01012-1
- By:
- Publication type:
- Article
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Important factors for achieving survival of five years or more in non-small cell lung cancer patients with distant metastasis.
- Published in:
- Oncology Letters, 2014, v. 8, n. 1, p. 327, doi. 10.3892/ol.2014.2107
- By:
- Publication type:
- Article